Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Trans R Soc Trop Med Hyg. 2013 Jul;107(7):451-6. doi: 10.1093/trstmh/trt037. Epub 2013 Jun 13.
Estimation of performance status (PS) has been assessed as a tool to determine which patients with newly diagnosed pulmonary TB (PTB) are most at risk of dying. This simple prediction rule has not been validated in patients with PTB with different background characteristics and from different geographic areas.
A retrospective cohort study was conducted in two Japanese hospitals in different regions and included 432 inpatients with newly diagnosed smear-positive non-multidrug-resistant lung TB without HIV infection. The patients had a mean ± SD age of 64.9 ± 19.7 years and 135 were female (31.3%). Detailed nursing charts were reviewed to estimate PS, which was graded 0 (best condition), 1, 2, 3 or 4 (worst condition), for each patient.
Single variable and multivariable Cox regression analyses models revealed that a one-point increase in PS was associated with a 2.8-fold (95% CI 2.2-3.6) and 2.3-fold (95% CI 1.8-3.0), adjusted for age, gender, comorbidities and treatment regimen, increase in the HR for death (p < 0.001 for both models). Kaplan-Meier curves also showed a significant difference in mortality among different PS groups (p < 0.001).
PS was strongly associated with mortality from PTB in the study cohort. Estimation of PS at the start of treatment for newly diagnosed PTB patients could be a useful tool in case management in resource-limited countries.
目前已经将体能状态(PS)评估作为一种工具,用于确定新发肺结核(PTB)患者中哪些患者死亡风险最高。但这种简单的预测规则尚未在不同背景特征和不同地理区域的 PTB 患者中得到验证。
这是一项在日本两个不同地区的医院进行的回顾性队列研究,共纳入 432 例新诊断为痰涂片阳性非耐多药肺结核且无 HIV 感染的住院患者。患者的平均年龄(SD)为 64.9(19.7)岁,女性 135 例(31.3%)。详细的护理图表用于评估 PS,每位患者的 PS 评分分为 0(最佳状态)、1、2、3 或 4(最差状态)。
单变量和多变量 Cox 回归分析模型显示,PS 每增加 1 分,死亡风险调整后 HR 分别增加 2.8 倍(95%CI 2.2-3.6)和 2.3 倍(95%CI 1.8-3.0)(p<0.001,两种模型均适用)。Kaplan-Meier 曲线也显示不同 PS 组之间死亡率存在显著差异(p<0.001)。
在研究队列中,PS 与 PTB 死亡率密切相关。在资源有限的国家,对新发 PTB 患者开始治疗时进行 PS 评估可能是病例管理的有用工具。